论文标题
比较基线协变量调整方法的平均生存时间
Comparison of Baseline Covariate Adjustment Methods for Restricted Mean Survival Time
论文作者
论文摘要
受限制的平均生存时间是一种临床上易于解释的措施,不需要任何比例危害的假设。我们专注于两种直接建模生存时间并调整协变量的方法。一种是使用剩下的一口气计算每个受试者的伪生期限,然后使用所有伪值进行模型分析来调整协变量。伪生存时间用于在模型分析中反映审查受试者的信息。另一种方法使用对审查权重(IPCW)的逆概率调整审查受试者时观察到的事件时间的受试者对协变量进行调整。本文根据简单的示例数据集和计算机模拟来评估这两种方法的性能。简单的示例说明了两种方法的直观行为。使用使用伪存在时间的方法,很难解释伪值。我们确认,由于许多审查数据,因此伪苏生的时间与原发性胆管炎临床试验中获得的实际数据不同。在模拟中,发现使用IPCW的方法更强大。即使在审查员发病率和协变量方面存在群体差异,使用IPCW的方法仍具有1型错误率的名义显着性水平。我们得出的结论是,在调整协变量时,应使用IPCW方法来估计限制的平均生存时间。
The restricted mean survival time is a clinically easy-to-interpret measure that does not require any assumption of proportional hazards. We focus on two ways to directly model the survival time and adjust the covariates. One is to calculate the pseudo-survival time for each subject using leave-one-out, and then perform a model analysis using all pseudo-values to adjust for covariates. The pseudo-survival time is used to reflect information of censored subjects in the model analysis. The other method adjusts for covariates using subjects for whom the time-to-event was observed while adjusting for the censored subjects using the inverse probability of censoring weighting (IPCW). This paper evaluates the performance of these two methods in terms of the power to detect group differences through a simple example dataset and computer simulations. The simple example illustrates the intuitive behavior of the two methods. With the method using pseudo-survival times, it is difficult to interpret the pseudo-values. We confirm that the pseudo-survival times are different from the actual data obtained in a primary biliary cholangitis clinical trial because of the many censored data. In the simulations, the method using IPCW is found to be more powerful. Even in the case of group differences with respect to the censor incidence rates and covariates, the method using IPCW maintains a nominal significance level for the type-1 error rate. We conclude that the IPCW method should be used to estimate the restricted mean survival time when adjusting the covariates.